A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
about
Peptide Vaccine: Progress and ChallengesNew developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus.Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerizationAchieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit modelMHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthraxStochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationAnthrax vaccines: present status and future prospects.Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.The promise and challenge of epitope-focused vaccines.
P2860
Q26851329-8F2CF36D-EF8C-46C4-8538-991AC1296207Q34066161-24E0DADA-9D26-4B8F-B0B3-8D6DA2932C3DQ35031839-663605E4-AE10-4EF2-A0D9-2289BF98144CQ35341887-41C3A0E7-2949-4BBE-B845-93285BCE5745Q35758457-1AF3F8E2-13A3-452C-B1E0-C5C33D47B276Q35900460-8FDD82A3-95C6-45C8-B7F9-8F78AFE90BFBQ36007463-225E2073-8793-4FC8-A6F1-047DC9FFDA77Q36159352-67EA6A96-EB54-4BD1-98F0-6BBDF0E6E14CQ36482706-0CB68B02-AA80-4566-B7B2-B7843F368F9EQ36668524-A5857BF4-F667-4048-8559-891F6CFCF174Q36733960-4E0BE41E-180A-4A0D-ACC7-81462933D148Q38132268-CAD1BE0B-CFA2-4351-AF3D-0A462D050D1DQ38869738-DE5CD946-BE37-45E4-B6F5-69E4FD7FFCFCQ40722956-9A4385EB-65BE-4634-9BA1-052CBD40763B
P2860
A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@ast
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@en
type
label
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@ast
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@en
prefLabel
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@ast
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@en
P2093
P356
P1476
A synthetic peptide vaccine di ...... bbits from inhalation anthrax.
@en
P2093
Jon Oscherwitz
Kemp B Cease
P304
P356
10.4049/JIMMUNOL.1001749
P407
P577
2010-08-09T00:00:00Z